MDLinx Psychiatry is your one-stop shop for the peer-reviewed journal articles published in your field. We sort, rank and summarize the literature within 24 hours – hot off the presses! – so you can stay current without drowning in those piles of Current Psychiatry, Bipolar Disorders, and American Journal of Psychiatry. Also find bonus content like clinical pearls from The Smartest Psychiatrist Physician Review and daily quiz competition. Not sure where to start? Skim some of the recent “must read” articles highlighted by our own physician editor D. Scott Cunningham, MD, PhD.
Your Unread Messages in Psychiatry
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pharmacologic Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Depression increases risk of stroke in women
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
321 Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units Full Text BMC Pharmacology & Toxicology, February 15, 2013 Review Article
322 The Declining Efficacy of Naltrexone Pharmacotherapy for Alcohol Use Disorders Over Time: A Multivariate Meta-Analysis Alcoholism: Clinical and Experimental Research, February 14, 2013
323 Clinical outcomes of long-acting risperidone in recent versus long-term diagnosed Belgian schizophrenic patients Early Intervention in Psychiatry, February 14, 2013 Clinical Article
324 A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania International Journal of Psychiatry in Clinical Practice, February 14, 2013 Clinical Article
325 Hippocampal Granule Neuron Number and Dentate Gyrus Volume in Antidepressant-Treated and Untreated Major Depression Neuropsychopharmacology, February 14, 2013 Review Article
326 The Selective Dopamine beta-Hydroxylase Inhibitor Nepicastat Attenuates Multiple Aspects of Cocaine-Seeking Behavior Neuropsychopharmacology, February 14, 2013 Review Article
327 Clonazepam for the Treatment of Panic Disorder Current Drug Targets, February 13, 2013 Review Article Clinical Article
328 A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder International Journal of Neuropsychopharmacology, February 13, 2013 Clinical Article
329 Comparison of methohexital and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders Journal of Psychiatric Research, February 13, 2013 Clinical Article
330 Modification of cocaine self-administration by buspirone (buspar): potential involvement of D3 and D4 dopamine receptors International Journal of Neuropsychopharmacology, February 13, 2013 Review Article
331 Striatal glutamate and the conversion to psychosis: a prospective 1 H-MRS imaging study International Journal of Neuropsychopharmacology, February 13, 2013 Review Article
332 A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil Addictive Behaviours, February 13, 2013 Clinical Article
333 Bone Loss Associated with Hyperprolactinemia in Patients with Schizophrenia Clinical Schizophrenia & Related Psychoses, February 12, 2013 Clinical Article
334 Methadone Dosing and Prescribed Medication Use in a Prospective Cohort of Opioid-Dependent Pregnant Women Addiction, February 12, 2013 Clinical Article
335 Improving Treatment Adherence in Your Patients with Schizophrenia: The STAY Initiative Clinical Drug Investigation, February 12, 2013 Review Article
336 Employment-Based Reinforcement of Adherence to Oral Naltrexone Treatment in Unemployed Injection Drug Users. Experimental and Clinical Psychopharmacology, February 12, 2013 Review Article
337 Prevalence of Concomitant Use of Alcohol and Sedative-Hypnotic Drugs in Middle and Older Aged Persons: A Systematic Review Annals of Pharmacotherapy, February 12, 2013 Review Article
338 Torsades de Pointes After Administration of Low-Dose Aripiprazole Annals of Pharmacotherapy, February 12, 2013 Clinical Article
339 Recurrent major depressive disorder: Imbalance of neurokinin (NK)-1 and NK-2 receptor expression in monocytes Pharmacological Research , February 12, 2013 Review Article
340 Kava for the Treatment of Generalized Anxiety Disorder RCT: Analysis of Adverse Reactions, Liver Function, Addiction, and Sexual Effects Phytotherapy Research, February 11, 2013 Review Article
As published in the American Journal of Obstetrics and Gynecology, risk factors for postpartum depression among abused women included age 15-19 (aOR=2.29) and > 35 years of age (aOR=2.33). In non-abused women, risk factors for postpartum depression include unemployment (aOR=1.41), foreign birth (aOR=2.04), and low income (aOR=1.68). Postpartum depression was also associated with women abused prior to pregnancy (aOR=3.28), abuse beginning postpartum (aOR=4.76), and abuse resuming postpartum (aOR=3.81).
Read the article summaryAs published in the British Journal of Psychiatry, low cardiovascular fitness at 18 years of age (n = 1,117,292; follow-up, 3-40 y) is associated with an increased risk of severe depression (HR = 1.96).
Read the article summaryAs published in Clinical Drug Investigation, an initial amisulpride dose of 800 mg (n=38) is more effective that 400 mg with dose titration (n=30) in patients with an acute exacerbation of schizophrenia. A greater number of patients in the 800 mg group than the 400 mg with dose titration group had a 30% reduction in the Positive and Negative Symptom Scale after 4 (68.4% vs. 40.0%) and 6 weeks (71.1% vs. 43.3%).
Read the article summary1 Post-traumatic stress disorder: new directions in pharmacotherapy Advances in Psychiatric Treatment, May 3, 2013 Review Article
2 The Combined Treatment of Venlafaxine and Quetiapine for Treatment-Resistant Depression: A Clinical Study The Journal of Neuropsychiatry & Clinical Neurosciences, May 21, 2013
3 Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study Clinical Neuropharmacology, May 16, 2013
4 Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers Human Psychopharmacology: Clinical and Experimental, May 13, 2013
5 Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review Expert Opinion on Pharmacotherapy, May 22, 2013
6 Lithiums role in neural plasticity and its implications for mood disorders Acta Psychiatrica Scandinavica, May 1, 2013 Review Article
7 Benzodiazepines for psychosis-induced aggression or agitation Cochrane Reviews, May 9, 2013
8 Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimers disease Alzheimer's & Dementia, May 14, 2013 Review Article
9 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013 Free full text
10 Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: A double blind, placebo-controlled study Psychiatry Research, May 2, 2013
11 Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial Schizophrenia Research, May 6, 2013
12 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013
13 Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial Journal of Affective Disorders, May 17, 2013
14 Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids Addictive Behaviours, May 24, 2013
15 Mood disorders and complementary and alternative medicine: a literature review Neuropsychiatric Disease and Treatment, May 29, 2013 Free full text Review Article
16 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013 Evidence Based Medicine
17 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013 Evidence Based Medicine
18 Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy Addiction, May 15, 2013
19 Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders Neuropsychiatric Disease and Treatment, May 7, 2013 Free full text
20 Amphetamine, past and present - a pharmacological and clinical perspective Journal of Psychopharmacology, May 16, 2013 Review Article
Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close